Product image of Inovira (Inosine Pranobex) supplied by GNH India

Inovira

Active Ingredient:
Inosine Pranobex
Origin:
EU

Inovira (Inosine Pranobex)

Inosine Pranobex, the active ingredient in Inovira, is an immunostimulant presented as an oral tablet for oral administration. It is employed to enhance immune function in viral infections such as herpes simplex, influenza, and in patients with immunodeficiency‑related viral diseases.

GNH India supplies Inovira as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution channels aligned to EU regulatory standards and ensures product quality through rigorous quality‑control processes.

Manufacturer / TM Owner

Sanience S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Inosine Pranobex is used to modulate immune responses in viral infections and related conditions.

  • Herpes simplex virus infections: reduces lesion frequency and accelerates healing.
  • Influenza and other acute viral respiratory infections: shortens disease duration and alleviates symptoms.
  • Subacute sclerosing panencephalitis (SSPE): supports antiviral activity in progressive measles complications.
  • Human papillomavirus (HPV) warts: promotes regression of cutaneous lesions.
  • Immunodeficiency‑related viral infections: enhances host defense against opportunistic viruses.

How It Works

  • Inosine Pranobex modulates the immune system by stimulating T‑cell proliferation and natural killer (NK) cell activity, while increasing the production of cytokines such as interferon‑α and interleukin‑2. This combined cellular and cytokine activation produces a broad antiviral effect that helps the body control and clear viral pathogens.

Side Effects

Inosine Pranobex may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional light‑headedness.
  • Fatigue: feeling of reduced energy.
  • Gastrointestinal discomfort: abdominal pain or cramping.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Severe allergic reaction: anaphylaxis, swelling of face or throat.
  • Hepatotoxicity: abnormal liver enzyme elevations.
  • Hematologic abnormalities: leukopenia or thrombocytopenia.
  • Cardiac arrhythmias: irregular heart rhythm in susceptible individuals.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

Before initiating therapy with Inosine Pranobex, consider the following precautions.

  • Pregnancy: safety not established; use only if potential benefit justifies risk.
  • Breastfeeding: unknown excretion; weigh benefits against potential infant exposure.
  • Liver disease: monitor hepatic function regularly.
  • Renal impairment: dose adjustment may be required based on renal function.
  • Immunocompromised patients: close clinical monitoring is advised.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Inosine Pranobex can interact with other medicines; awareness of potential interactions helps maintain safety.

Major Interactions (Avoid)

  • Immunosuppressants (e.g., cyclosporine, tacrolimus): may counteract immunostimulatory effect.
  • Live vaccines: increased risk of adverse vaccine reactions.

Moderate Interactions (Monitor Closely)

  • Anticoagulants (e.g., warfarin): possible alteration of coagulation parameters.
  • Antiretroviral agents: potential for reduced antiviral efficacy.
  • CNS depressants: may enhance sedation or dizziness.
  • Herbal immunomodulators (e.g., echinacea): additive immune stimulation.
  • Diuretics: monitor electrolyte balance.

Frequently Asked Questions

Inovira, containing Inosine Pranobex, is prescribed to support the immune system in viral infections such as herpes simplex, influenza and other acute respiratory viruses, as well as in subacute sclerosing panencephalitis, HPV‑related warts, and viral infections that occur in immunodeficient patients.

Inosine Pranobex enhances immune function by stimulating T‑cell and natural killer cell activity and increasing cytokine production, including interferon‑α and interleukin‑2. This combined cellular activation creates a broad antiviral environment that helps the body control and eliminate viral pathogens.

The dosage of Inovira is determined by the prescribing clinician based on the specific indication, patient age, weight, renal and hepatic function, and overall clinical condition. Patients should follow the exact regimen provided by their healthcare professional.

Safety data for Inosine Pranobex in pregnancy and lactation are limited. It should only be used if the potential therapeutic benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Inovira, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike direct‑acting antivirals that target specific viral enzymes, Inovira acts as an immunostimulant, enhancing the host’s immune response rather than inhibiting a viral protein. This broader mechanism can be advantageous in mixed or resistant viral infections, but it may not replace virus‑specific agents where those are indicated.

Inovira tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Inovira is taken orally as a tablet with water. It is usually administered with or without food according to the prescribing physician’s instructions. Patients should swallow the tablet whole and not crush or chew it unless directed otherwise.

Serious adverse reactions, though rare, include severe allergic responses such as anaphylaxis, liver toxicity manifested by elevated enzymes, hematologic abnormalities like leukopenia or thrombocytopenia, and rare severe skin conditions such as Stevens‑Johnson syndrome. Prompt medical attention is required if any of these occur.

Inovira is contraindicated in individuals with known hypersensitivity to Inosine Pranobex or any tablet excipients. Patients with uncontrolled severe liver disease, active autoimmune disorders, or those receiving live vaccines should avoid use unless a healthcare professional determines that benefits outweigh risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Inosine Pranobex

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT